Recombinant galectin-1 proved to be efficient in ameliorating inflammatory diseases such as type-1 diabetes (Perone et al., 2009[42]) and rheumatoid arthritis (Rabinovitch et al., 1999[44]). Here, LGALS1 is linked to type 1 diabetes mellitus.